DFTX — Definium Therapeutics Share News
0.000.00%
Last trade - 00:00Definium Therapeutics dips after announcing $500 mln equity offering
U.S. STOCKS ON THE MOVE-Abbvie, AMC, Getty
Definium Therapeutics jumps on depression drug trial data
U.S. STOCKS ON THE MOVE-Getty Images, Ecarx, Maplight Therapeutics
U.S. STOCKS ON THE MOVE-Definium, Regenxbio, Arcosa
U.S. STOCKS ON THE MOVE- Visteon, Incyte, Apogee
Definium Therapeutics jumps as depression drug shows positive late-stage trial data
Definium's LSD-based depression pill delivers strong late-stage results, shares surge (updated)
Brief: Definium Therapeutics Says Study Of DT120 ODT Met Primary All Key Secondary Efficacy Endpoints
Definium's LSD-based pill reduces depression symptoms in late-stage trial
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
Brief: Definium Therapeutics Announces First Patient Dosed In Ascend
Definium Therapeutics Q1 net loss widens on higher R&D costs
Brief: Definium Therapeutics Inc Q1 Net Income USD -77.098 Million
U.S. STOCKS ON THE MOVE-Adobe, Biogen, Sable
Psychedelic drug developers rise after Trump signals regulatory support
U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO
U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen
Psychedelic drug developers rally as Trump orders FDA to expedite reviews (updated)